Literature DB >> 16170138

Tetracycline induced green conjunctival pigment deposits.

V L Morrison, D O Kikkawa, B G Herndier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170138      PMCID: PMC1772882          DOI: 10.1136/bjo.2005.069526

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  12 in total

Review 1.  A status report on the medical management of rosacea: focus on topical therapies.

Authors:  James Q Del Rosso
Journal:  Cutis       Date:  2002-11

2.  Minocycline-induced ocular pigmentation.

Authors:  Yasmin Siddiqui Bradfield; Dennis M Robertson; Diva R Salomao; Thomas P Link; Jay A Rostvold
Journal:  Arch Ophthalmol       Date:  2003-01

3.  Diagnosis and treatment of ocular rosacea.

Authors:  S I Brown; L Shahinian
Journal:  Ophthalmology       Date:  1978-08       Impact factor: 12.079

4.  Minocycline-induced discolouration of the sclerae.

Authors:  R A Sabroe; C B Archer; D Harlow; J W Bradfield; R D Peachey
Journal:  Br J Dermatol       Date:  1996-08       Impact factor: 9.302

Review 5.  Minocycline-induced scleral pigmentation.

Authors:  F T Fraunfelder; J A Randall
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

6.  Conjunctival pigmentation associated with tetracycline medication.

Authors:  D M Brothers; A A Hidayat
Journal:  Ophthalmology       Date:  1981-12       Impact factor: 12.079

7.  Nail, skin, and scleral pigmentation induced by minocycline.

Authors:  V L Angeloni; S J Salasche; R Ortiz
Journal:  Cutis       Date:  1987-09

Review 8.  Update and future of systemic acne treatment.

Authors:  Christos C Zouboulis; Jaime Piquero-Martin
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

Review 9.  Minocycline-induced pigmentation. Incidence, prevention and management.

Authors:  D Eisen; M D Hakim
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

10.  Distribution of tetracycline in the conjunctiva of patients on long term systemic doses.

Authors:  P N Dilly; I A Mackie
Journal:  Br J Ophthalmol       Date:  1985-01       Impact factor: 4.638

View more
  2 in total

1.  Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.

Authors:  Manfred Hauben; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  Fluorescence in the Sclera, Nails, and Teeth Secondary to Favipiravir Use for COVID-19 Infections.

Authors:  Emel Öztürk Durmaz; Deniz Demircioğlu
Journal:  J Clin Aesthet Dermatol       Date:  2022-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.